Antiemeetilised, mineralisatsiooni soodustavad ja detoksitseerivad ravimid

This Estonian public procurement for antiemetic, mineralising and detoxifying drugs (specifically ondansetron A04AA01) is open only to suppliers who can certify that Russian-linked subcontractors/tier-1 suppliers account for ≤10 % of contract value and who, if bidding as a consortium, appoint one authorised representative and file the joint-bid mandate—both conditions are mandatory pass/fail.

Tälle asiakirjalle ei ole saatavilla yhteenvetoa.

This document merely instructs bidders to submit the “Application to Participate” (Form III of Annex 3) – a mandatory administrative step – and gives no detail on product specifications, required qualifications or award criteria, so suppliers cannot yet judge their fit for the anti-emetic/mineralising/detoxifying medicines framework tender.

Tartu University Hospital’s 100 %-price-only, lowest-bid-wins framework tender for ondansetron, granisetron, palonosetron+netupitant and aprepitant anti-emetic/detox medicines is open to any supplier that can simply quote an all-in ex-VAT lump-sum per Annex 1 and deliver the listed quantities—no quality weighting, no e-auction, no mandatory certifications beyond normal market authorisation—so bid only if you can undercut on price while still meeting Estonian pharmaceutical supply rules.

This open Estonian procurement by Tartu Ülikikum seeks an 11-lot framework contract for anti-emetics, remineralising and detoxifying medicines (CPV 33650000-1) and will pre-qualify bidders solely through the standard ESPD e-form, so any EU/EEA pharmaceutical supplier that can legally market the listed products and submit the electronic ESPD before the deadline should consider bidding.

Tartu University Hospital is running an 11-lot, open-procurement for anti-emetics, mineralising and detoxifying medicines under a 2-month framework contract: mandatory compliance with Estonian Public Procurement Act, EU/EEA/WTO GPA establishment, 2-month bid validity, 7-day contract signing deadline, and acceptance of “or equivalent” standards; quantities and exact technical specs are in Annex 1 (not shown), so only suppliers already holding or able to source equivalent registered pharmaceuticals should bid.

Tartu University Hospital seeks a supplier for antiemetic, mineralization-promoting and detoxifying medicines under a framework agreement until 31 Oct 2027, requiring next-day delivery to its Tartu pharmacy, a minimum 50 % remaining shelf-life, and the ability to supply up to 130 % of tendered quantities, with no fixed purchase obligation but mandatory compliance with the product list and prices in Annex 1.

This document is merely a blank power-of-attorney template (.doc) for signing the offer—no tender requirements, qualifications, or evaluation criteria are stated—so it gives bidders no actionable information for deciding whether to bid.

This legacy-format "Joint Bidder Authorization" form contains only a power-of-attorney template for consortium bidding and reveals nothing about the mandatory product specifications, required qualifications or award criteria for the University of Tartu Hospital’s framework tender for anti-emetics, remineralising and detoxifying medicines, so bidders must consult Annex 1 of the full tender file before deciding to proceed.